Arkolith/Insider Trading/AEON/Form 4

Fischer Jost

DirectorAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Jul 24, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
2 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2023Grant(A)13K——13K
Jul 21, 2023Grant(A)2K——2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Grant(A)35K—$035K
Jul 21, 2023Grant(A)22K—$022K
Jul 21, 2023Grant(A)20K—$020K
Jul 21, 2023Grant(A)6K—$06K
Jul 21, 2023Grant(A)19K—$019K
Jul 21, 2023Grant(A)21K—$012K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-083565) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML